ESC 365 - Myocardial fibrosis predicts ventricular arrhythmias and sudden death after cardiac electronic device implantation

EHRA Premium Access

Myocardial fibrosis predicts ventricular arrhythmias and sudden death after cardiac electronic device implantation

Session: Young Investigator Award - Clinical

Topic: Device Treatment

Speaker: Doctor A. Zegard (Birmingham, GB)

Event: EHRA 2022

Congress Presentation

Add to my library

About the speaker

Doctor Abbasin Zegard

Aston University, Birmingham (United Kingdom of Great Britain & Northern Ireland)

2 presentations

0 follower

4 more presentations in this session

Comparison of the accuracy of contact force measurement in four commercially available force-sensing ablation catheters

Speaker: Mr T. Kueffer (Bern, CH)

Comparison of various late gadolinium enhancement magnetic resonance imaging methods to high-definition voltage and activation mapping for detection of atrial cardiomyopathy

Speaker: Doctor M. Eichenlaub (Bad Krozingen, DE)

A positive toxicology screen is a rare finding in sports-related sudden cardiac deaths

Speaker: Doctor C. Hansen (Copenhagen, DK)

More than half of all sudden cardiac deaths occur in persons without a history of cardiovascular disease: A study of 54,028 deaths in Denmark

Speaker: Doctor T. Lynge (Copenhagen, DK)

Access the full session

Young Investigator Award - Clinical

Speakers: Doctor A. Zegard, Mr T. Kueffer, Doctor M. Eichenlaub, Doctor C. Hansen, Doctor T. Lynge

About the event

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources